+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Geriatric Medicines Market 2025-2029

  • PDF Icon

    Report

  • 231 Pages
  • February 2025
  • Region: Global
  • TechNavio
  • ID: 5849350
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The geriatric medicines market is forecasted to grow by USD 57.3 billion during 2024-2029, accelerating at a CAGR of 7.5% during the forecast period. The report on the geriatric medicines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, demand for personalized medicine, and increase in governments and ngo supports for elderly.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The geriatric medicines market is segmented as below:

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Type

  • Analgesics
  • Antidiabetics
  • Antihypertensives
  • Statins
  • Others

By Therapeutic Area

  • Cardiovascular
  • Neurology
  • Respiratory
  • Others

By Form Factor

  • Tablets
  • Capsules
  • Liquids
  • Injectables

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rise in therapeutic approaches as one of the prime reasons driving the geriatric medicines market growth during the next few years. Also, strategic partnership and acquisitions and active role play of senior citizens in monitoring their health remotely will lead to sizable demand in the market.

The report on the geriatric medicines market covers the following areas:

  • Geriatric Medicines Market sizing
  • Geriatric Medicines Market forecast
  • Geriatric Medicines Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading geriatric medicines market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cipla Inc., DR Reddys Laboratories Ltd., Eli Lilly and Co., Endo International PLC, GlaxoSmithKline PLC, Lupin Ltd., Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the geriatric medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Market Segmentation by Form Factor
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ billion)
Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Geriatric Medicines Market 2019 - 2023
Historic Market Size - Data Table on Global Geriatric Medicines Market 2019 - 2023 ($ billion)
5.2 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ billion)
5.4 Therapeutic Area segment analysis 2019 - 2023
Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ billion)
5.5 Form Factor segment analysis 2019 - 2023
Historic Market Size - Form Factor Segment 2019 - 2023 ($ billion)
5.6 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.7 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI on Global Geriatric Medicines Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel
8.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
8.3 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
8.4 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
8.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ billion)
Data Table on Market opportunity by Distribution Channel ($ billion)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Analgesics - Market size and forecast 2024-2029
Chart on Analgesics - Market size and forecast 2024-2029 ($ billion)
Data Table on Analgesics - Market size and forecast 2024-2029 ($ billion)
Chart on Analgesics - Year-over-year growth 2024-2029 (%)
Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
9.4 Antidiabetics - Market size and forecast 2024-2029
Chart on Antidiabetics - Market size and forecast 2024-2029 ($ billion)
Data Table on Antidiabetics - Market size and forecast 2024-2029 ($ billion)
Chart on Antidiabetics - Year-over-year growth 2024-2029 (%)
Data Table on Antidiabetics - Year-over-year growth 2024-2029 (%)
9.5 Antihypertensives - Market size and forecast 2024-2029
Chart on Antihypertensives - Market size and forecast 2024-2029 ($ billion)
Data Table on Antihypertensives - Market size and forecast 2024-2029 ($ billion)
Chart on Antihypertensives - Year-over-year growth 2024-2029 (%)
Data Table on Antihypertensives - Year-over-year growth 2024-2029 (%)
9.6 Statins - Market size and forecast 2024-2029
Chart on Statins - Market size and forecast 2024-2029 ($ billion)
Data Table on Statins - Market size and forecast 2024-2029 ($ billion)
Chart on Statins - Year-over-year growth 2024-2029 (%)
Data Table on Statins - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Type
Market opportunity by Type ($ billion)
Data Table on Market opportunity by Type ($ billion)
10 Market Segmentation by Therapeutic Area
10.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
10.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
10.3 Cardiovascular - Market size and forecast 2024-2029
Chart on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
10.4 Neurology - Market size and forecast 2024-2029
Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
Chart on Neurology - Year-over-year growth 2024-2029 (%)
Data Table on Neurology - Year-over-year growth 2024-2029 (%)
10.5 Respiratory - Market size and forecast 2024-2029
Chart on Respiratory - Market size and forecast 2024-2029 ($ billion)
Data Table on Respiratory - Market size and forecast 2024-2029 ($ billion)
Chart on Respiratory - Year-over-year growth 2024-2029 (%)
Data Table on Respiratory - Year-over-year growth 2024-2029 (%)
10.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ billion)
Data Table on Market opportunity by Therapeutic Area ($ billion)
11 Market Segmentation by Form Factor
11.1 Market segments
Chart on Form Factor - Market share 2024-2029 (%)
Data Table on Form Factor - Market share 2024-2029 (%)
11.2 Comparison by Form Factor
Chart on Comparison by Form Factor
Data Table on Comparison by Form Factor
11.3 Tablets - Market size and forecast 2024-2029
Chart on Tablets - Market size and forecast 2024-2029 ($ billion)
Data Table on Tablets - Market size and forecast 2024-2029 ($ billion)
Chart on Tablets - Year-over-year growth 2024-2029 (%)
Data Table on Tablets - Year-over-year growth 2024-2029 (%)
11.4 Capsules - Market size and forecast 2024-2029
Chart on Capsules - Market size and forecast 2024-2029 ($ billion)
Data Table on Capsules - Market size and forecast 2024-2029 ($ billion)
Chart on Capsules - Year-over-year growth 2024-2029 (%)
Data Table on Capsules - Year-over-year growth 2024-2029 (%)
11.5 Liquids - Market size and forecast 2024-2029
Chart on Liquids - Market size and forecast 2024-2029 ($ billion)
Data Table on Liquids - Market size and forecast 2024-2029 ($ billion)
Chart on Liquids - Year-over-year growth 2024-2029 (%)
Data Table on Liquids - Year-over-year growth 2024-2029 (%)
11.6 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ billion)
Data Table on Injectables - Market size and forecast 2024-2029 ($ billion)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
11.7 Market opportunity by Form Factor
Market opportunity by Form Factor ($ billion)
Data Table on Market opportunity by Form Factor ($ billion)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ billion)
Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ billion)
Data Table on China - Market size and forecast 2024-2029 ($ billion)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
13.11 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ billion)
Data Table on India - Market size and forecast 2024-2029 ($ billion)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
13.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ billion)
Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
13.13 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
13.14 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ billion)
Data Table on France - Market size and forecast 2024-2029 ($ billion)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
13.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
13.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ billion)
Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
14 Drivers, Challenges, and Opportunity/Restraints
14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
Companies covered
16.2 Company ranking index
Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT
16.5 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product/Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
16.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product/Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
16.7 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product/Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
16.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product/Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
16.9 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
16.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product/Service
Eli Lilly and Co. - Key offerings
SWOT
16.11 Endo International Plc
Endo International Plc - Overview
Endo International Plc - Business segments
Endo International Plc - Key news
Endo International Plc - Key offerings
Endo International Plc - Segment focus
SWOT
16.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
16.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
16.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
16.15 Otsuka Holdings Co. Ltd.
Otsuka Holdings Co. Ltd. - Overview
Otsuka Holdings Co. Ltd. - Business segments
Otsuka Holdings Co. Ltd. - Key news
Otsuka Holdings Co. Ltd. - Key offerings
Otsuka Holdings Co. Ltd. - Segment focus
SWOT
16.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product/Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
16.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
16.18 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
17 Appendix
17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
Research methodology
17.5 Data procurement
Information sources
17.6 Data validation
Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 8: Executive Summary - Chart on Market Segmentation by Form Factor
Exhibits 9: Executive Summary - Chart on Incremental Growth
Exhibits 10: Executive Summary - Data Table on Incremental Growth
Exhibits 11: Executive Summary - Chart on Company Market Positioning
Exhibits 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 13: Overview on criticality of inputs and factors of differentiation
Exhibits 14: Overview on factors of disruption
Exhibits 15: Impact of drivers and challenges in 2024 and 2029
Exhibits 16: Parent Market
Exhibits 17: Data Table on - Parent Market
Exhibits 18: Market characteristics analysis
Exhibits 19: Value chain analysis
Exhibits 20: Offerings of companies included in the market definition
Exhibits 21: Market segments
Exhibits 22: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 23: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 26: Historic Market Size - Data Table on Global Geriatric Medicines Market 2019 - 2023 ($ billion)
Exhibits 27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
Exhibits 28: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
Exhibits 29: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ billion)
Exhibits 30: Historic Market Size - Form Factor Segment 2019 - 2023 ($ billion)
Exhibits 31: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits 32: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits 33: Five forces analysis - Comparison between 2024 and 2029
Exhibits 34: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 37: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 38: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 39: Chart on Market condition - Five forces 2024 and 2029
Exhibits 40: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 41: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 42: Chart on Comparison by Distribution Channel
Exhibits 43: Data Table on Comparison by Distribution Channel
Exhibits 44: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 45: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 46: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 48: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 49: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 50: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 51: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 52: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 53: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 54: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 55: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 56: Market opportunity by Distribution Channel ($ billion)
Exhibits 57: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 58: Chart on Type - Market share 2024-2029 (%)
Exhibits 59: Data Table on Type - Market share 2024-2029 (%)
Exhibits 60: Chart on Comparison by Type
Exhibits 61: Data Table on Comparison by Type
Exhibits 62: Chart on Analgesics - Market size and forecast 2024-2029 ($ billion)
Exhibits 63: Data Table on Analgesics - Market size and forecast 2024-2029 ($ billion)
Exhibits 64: Chart on Analgesics - Year-over-year growth 2024-2029 (%)
Exhibits 65: Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
Exhibits 66: Chart on Antidiabetics - Market size and forecast 2024-2029 ($ billion)
Exhibits 67: Data Table on Antidiabetics - Market size and forecast 2024-2029 ($ billion)
Exhibits 68: Chart on Antidiabetics - Year-over-year growth 2024-2029 (%)
Exhibits 69: Data Table on Antidiabetics - Year-over-year growth 2024-2029 (%)
Exhibits 70: Chart on Antihypertensives - Market size and forecast 2024-2029 ($ billion)
Exhibits 71: Data Table on Antihypertensives - Market size and forecast 2024-2029 ($ billion)
Exhibits 72: Chart on Antihypertensives - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Antihypertensives - Year-over-year growth 2024-2029 (%)
Exhibits 74: Chart on Statins - Market size and forecast 2024-2029 ($ billion)
Exhibits 75: Data Table on Statins - Market size and forecast 2024-2029 ($ billion)
Exhibits 76: Chart on Statins - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Statins - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 79: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 80: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 82: Market opportunity by Type ($ billion)
Exhibits 83: Data Table on Market opportunity by Type ($ billion)
Exhibits 84: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 85: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 86: Chart on Comparison by Therapeutic Area
Exhibits 87: Data Table on Comparison by Therapeutic Area
Exhibits 88: Chart on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
Exhibits 89: Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
Exhibits 90: Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits 91: Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits 92: Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
Exhibits 93: Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
Exhibits 94: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 95: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 96: Chart on Respiratory - Market size and forecast 2024-2029 ($ billion)
Exhibits 97: Data Table on Respiratory - Market size and forecast 2024-2029 ($ billion)
Exhibits 98: Chart on Respiratory - Year-over-year growth 2024-2029 (%)
Exhibits 99: Data Table on Respiratory - Year-over-year growth 2024-2029 (%)
Exhibits 100: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 101: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 102: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 103: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 104: Market opportunity by Therapeutic Area ($ billion)
Exhibits 105: Data Table on Market opportunity by Therapeutic Area ($ billion)
Exhibits 106: Chart on Form Factor - Market share 2024-2029 (%)
Exhibits 107: Data Table on Form Factor - Market share 2024-2029 (%)
Exhibits 108: Chart on Comparison by Form Factor
Exhibits 109: Data Table on Comparison by Form Factor
Exhibits 110: Chart on Tablets - Market size and forecast 2024-2029 ($ billion)
Exhibits 111: Data Table on Tablets - Market size and forecast 2024-2029 ($ billion)
Exhibits 112: Chart on Tablets - Year-over-year growth 2024-2029 (%)
Exhibits 113: Data Table on Tablets - Year-over-year growth 2024-2029 (%)
Exhibits 114: Chart on Capsules - Market size and forecast 2024-2029 ($ billion)
Exhibits 115: Data Table on Capsules - Market size and forecast 2024-2029 ($ billion)
Exhibits 116: Chart on Capsules - Year-over-year growth 2024-2029 (%)
Exhibits 117: Data Table on Capsules - Year-over-year growth 2024-2029 (%)
Exhibits 118: Chart on Liquids - Market size and forecast 2024-2029 ($ billion)
Exhibits 119: Data Table on Liquids - Market size and forecast 2024-2029 ($ billion)
Exhibits 120: Chart on Liquids - Year-over-year growth 2024-2029 (%)
Exhibits 121: Data Table on Liquids - Year-over-year growth 2024-2029 (%)
Exhibits 122: Chart on Injectables - Market size and forecast 2024-2029 ($ billion)
Exhibits 123: Data Table on Injectables - Market size and forecast 2024-2029 ($ billion)
Exhibits 124: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 125: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 126: Market opportunity by Form Factor ($ billion)
Exhibits 127: Data Table on Market opportunity by Form Factor ($ billion)
Exhibits 128: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 129: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 130: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 131: Chart on Geographic comparison
Exhibits 132: Data Table on Geographic comparison
Exhibits 133: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 134: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 135: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 138: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 139: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 142: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 143: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 146: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 147: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 150: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 151: Chart on US - Year-over-year growth 2024-2029 (

Executive Summary

The following companies are recognized as the key players in the global geriatric medicines market: Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cipla Inc., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, GlaxoSmithKline Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in therapeutic approaches."

According to the report, one of the major drivers for this market is the growing geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Cipla Inc.
  • Dr Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Geriatric Medicine Market Size, Share & Trends Analysis Report By Therapeutics (Analgesics, Antihypertensive, Statins, Proton Pump Inhibitors), By Condition, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Geriatric Medicine Market Size, Share & Trends Analysis Report By Therapeutics (Analgesics, Antihypertensive, Statins, Proton Pump Inhibitors), By Condition, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Geriatric Medicines - Global Strategic Business Report - Product Image

Geriatric Medicines - Global Strategic Business Report

  • Report
  • 304 Pages
  • Global
From
Geriatric Medicine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Image

Geriatric Medicine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • 93 Pages
  • Global
From
Gastroparesis Drugs Market 2025-2029 - Product Image

Gastroparesis Drugs Market 2025-2029

  • Report
  • 198 Pages
  • Global
From
Proton Pump Inhibitors (ppis) Market 2025-2029 - Product Image

Proton Pump Inhibitors (ppis) Market 2025-2029

  • Report
  • 199 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.